Covered recipient · General Payments record
SCOTT A WATKINS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,627.46
- Reported across 343 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $820.71 | 52 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $237.40 | 16 |
| Lilly USA, LLC | $134.34 | 9 |
| PFIZER INC. | $77.41 | 5 |
| Corium, Inc. | $62.09 | 4 |
| GlaxoSmithKline, LLC. | $46.08 | 3 |
| Amgen Inc. | $44.05 | 3 |
| Acerta Pharma LLC | $33.28 | 2 |
| Merck Sharp & Dohme Corporation | $29.56 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.64 | 1 |
| Pulmonx Corporation | $27.53 | 1 |
| Lundbeck LLC | $21.62 | 1 |
| Otsuka America Pharmaceutical, Inc. | $18.65 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.47 | 1 |
| Astellas Pharma US Inc | $15.88 | 1 |
| Novo Nordisk AS | $15.64 | 1 |
| Exact Sciences Corporation | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (52)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.47 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312671 | CMS |
| ABBVIE INC. | $20.47 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312673 | CMS |
| ABBVIE INC. | $15.90 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312675 | CMS |
| ABBVIE INC. | $15.63 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312677 | CMS |
| ABBVIE INC. | $12.22 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312679 | CMS |
| ABBVIE INC. | $17.89 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312681 | CMS |
| ABBVIE INC. | $13.88 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312683 | CMS |
| ABBVIE INC. | $13.82 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312685 | CMS |
| ABBVIE INC. | $18.24 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312687 | CMS |
| ABBVIE INC. | $17.53 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312689 | CMS |
| ABBVIE INC. | $14.25 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312691 | CMS |
| ABBVIE INC. | $10.61 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312693 | CMS |
| ABBVIE INC. | $14.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312695 | CMS |
| ABBVIE INC. | $13.79 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312697 | CMS |
| ABBVIE INC. | $10.66 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312699 | CMS |
| ABBVIE INC. | $12.54 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106312701 | CMS |
| Amgen Inc. | $14.55 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116202475 | CMS |
| Amgen Inc. | $14.30 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116202480 | CMS |
| Amgen Inc. | $15.20 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117714226 | CMS |
| Astellas Pharma US Inc | $15.88 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268768 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.97 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104532050 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.31 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104277189 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $27.64 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086244250 | CMS |
| Corium, LLC | $32.62 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100072291 | CMS |
| Corium, LLC | $1.08 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100137751 | CMS |
| Corium, LLC | $1.91 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100141337 | CMS |
| Corium, LLC | $26.48 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100194808 | CMS |
| Exact Sciences Corporation | $13.07 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114945947 | CMS |
| GlaxoSmithKline, LLC. | $17.64 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116615978 | CMS |
| GlaxoSmithKline, LLC. | $14.95 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116381836 | CMS |
| GlaxoSmithKline, LLC. | $13.49 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116511001 | CMS |
| Lilly USA, LLC | $9.06 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135397963 | CMS |
| Lilly USA, LLC | $17.48 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135397961 | CMS |
| Lilly USA, LLC | $12.21 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135344719 | CMS |
| Lilly USA, LLC | $18.17 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135410269 | CMS |
| Lilly USA, LLC | $16.56 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135344722 | CMS |
| Lilly USA, LLC | $11.44 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135379834 | CMS |
| Lilly USA, LLC | $16.34 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135344726 | CMS |
| Lilly USA, LLC | $15.53 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135417895 | CMS |
| Lilly USA, LLC | $17.55 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135419569 | CMS |
| Lundbeck LLC | $21.62 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145979965 | CMS |
| Merck Sharp & Dohme LLC | $16.31 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141955845 | CMS |
| Merck Sharp & Dohme LLC | $13.25 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141615790 | CMS |
| Novartis Pharmaceuticals Corporation | $16.47 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087408508 | CMS |
| Novo Nordisk Inc | $15.64 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097014363 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.65 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119002713 | CMS |
| PFIZER INC. | $13.96 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131101447 | CMS |
| PFIZER INC. | $17.90 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131061790 | CMS |
| PFIZER INC. | $15.44 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131472359 | CMS |
| PFIZER INC. | $13.38 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131941489 | CMS |
| PFIZER INC. | $16.73 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132113205 | CMS |
| Pulmonx Corporation | $27.53 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087851852 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.